As a high-tech enterprise invested by Nanjing CHICO Pharmaceutical Co., Ltd., Anqing CHICO Pharmaceutical Co., Ltd is mainly engaged in the MAH/CDMO service of APIs and production of high-end pharmaceutical intermediates. Since inception, we have devoted ourselves to the research, development and production of small molecule targeted anti-tumor, anti-diabetic APIs, and pharmaceutical intermediates.
Regarding quality as number one priority, we have established a strict quality assurance system reference to GMP requirements. In accordance with the requirements of relevant EHS laws and regulations of China, we also have established a sound EHS management system and strive to create a safe, healthy, and clean working environment for our employees to achieve sustainable development.
Adhering to the business philosophy of "Consummate Service Convincing Honor", we strive to provide quality products and first-class service for customers relying on profound technical accumulation and outstanding professional quality. We sincerely welcome new and old customers at home and abroad to conduct business relations with us. We sincerely look forward to continuously enhancing mutual friendship through honest, high-quality, high- efficient and professional service. We will work with you to create a bright future!
more >
Year of Establishment:
2008
Total Assets(USD):
50,000,000 To 54,999,999
Total Number of Staff:
50 to 59
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer,Trading Company
R&D capacity:
Annual Turnover(USD):
50,000,000 To 54,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: